Ma; Dangshe
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ma; Dangshe.The latest application filed is for "radiolabeled anti-pd-l1 antibodies for immuno-pet imaging".
Company Profile
11.22.32
- Ma; Dangshe - Millwood NY
- Ma; Dangshe - Milwood NY
- Ma; Dangshe - New York NY
- Ma; Dangshe - Rockville MD
Patent Activity
| Patent | Date |
|---|---|
| Radiolabeled Anti-pd-l1 Antibodies For Immuno-pet Imaging App 20220184241 - Kelly; Marcus ; et al. | 2022-06-16 |
| Anti-cd8 Antibodies And Uses Thereof App 20210147542 - Giurleo; Jason T. ; et al. | 2021-05-20 |
| Radiolabeled Anti-lag3 Antibodies For Immuno-pet Imaging App 20210138096 - Kelly; Marcus ; et al. | 2021-05-13 |
| Radiolabeled Met Binding Proteins For Immuno-pet Imaging App 20210077638 - Kelly; Marcus ; et al. | 2021-03-18 |
| Radiolabeled anti-LAG3 antibodies for immuno-PET imaging Grant 10,905,784 - Kelly , et al. February 2, 2 | 2021-02-02 |
| Psma Antibody-drug Conjugates App 20210023094 - Ma; Dangshe ; et al. | 2021-01-28 |
| Site Specific Her2 Antibody Drug Conjugates App 20200377615 - MA; Dangshe ; et al. | 2020-12-03 |
| Radiolabeled Anti-pd-l1 Antibodies For Immuno-pet Imaging App 20200345872 - Kelly; Marcus ; et al. | 2020-11-05 |
| Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging Grant 10,736,976 - Kelly , et al. A | 2020-08-11 |
| Anti-CD8 antibodies and uses thereof Grant 10,730,944 - Giurleo , et al. | 2020-08-04 |
| Site specific HER2 antibody drug conjugates Grant 10,689,458 - Ma , et al. | 2020-06-23 |
| Antibodies And Antibody Fragments For Site-specific Conjugation App 20200069764 - MA; Dangshe ; et al. | 2020-03-05 |
| Anti-cd8 Antibodies And Uses Thereof App 20190023790 - Giurleo; Jason T. ; et al. | 2019-01-24 |
| Radiolabeled Anti-lag3 Antibodies For Immuno-pet Imaging App 20180228926 - Kelly; Marcus ; et al. | 2018-08-16 |
| Radiolabeled Anti-pd-l1 Antibodies For Immuno-pet Imaging App 20180161464 - Kelly; Marcus ; et al. | 2018-06-14 |
| Anti-IL-13 receptor alpha 2 antibodies and antibody-drug conjugates Grant 9,828,428 - Ma , et al. November 28, 2 | 2017-11-28 |
| Antibodies And Antibody Fragments For Site-specific Conjugation App 20170216452 - MA; Dangshe ; et al. | 2017-08-03 |
| PSMA antibodies and uses thereof Grant 9,695,248 - Maddon , et al. July 4, 2 | 2017-07-04 |
| Site Specific Her2 Antibody Drug Conjugates App 20170151341 - MA; Dangshe ; et al. | 2017-06-01 |
| Alpha emitting constructs and uses thereof Grant 9,289,519 - Scheinberg , et al. March 22, 2 | 2016-03-22 |
| Methods for killing PSMA-expressing, taxane-resistant cancer cells Grant 9,242,012 - Ma , et al. January 26, 2 | 2016-01-26 |
| Anti-il-13 Receptor Alpha 2 Antibodies And Antibody-drug Conjugates App 20150266962 - Ma; Dangshe ; et al. | 2015-09-24 |
| Psma Antibodies And Uses Thereof App 20150197577 - Maddon; Paul J. ; et al. | 2015-07-16 |
| Antibodies For The Treatment Of Clostridium Difficile-associated Infection And Disease App 20150175681 - Ma; Dangshe ; et al. | 2015-06-25 |
| Antibodies for the treatment of Clostridium difficile-associated infection and disease Grant 8,986,697 - Ma , et al. March 24, 2 | 2015-03-24 |
| Psma Antibodies And Uses Thereof App 20140286859 - Maddon; Paul J. ; et al. | 2014-09-25 |
| Alpha Emitting Constructs and Uses Thereof App 20130295008 - Scheinberg; David A. ; et al. | 2013-11-07 |
| Antibodies For The Treatment Of Clostridium Difficile-associated Infection And Disease App 20130202618 - Ma; Dangshe ; et al. | 2013-08-08 |
| Alpha-emitting constructs and uses thereof Grant 8,486,409 - Scheinberg , et al. July 16, 2 | 2013-07-16 |
| PSMA antibodies and uses thereof Grant 8,470,330 - Maddon , et al. June 25, 2 | 2013-06-25 |
| Compositions of PSMA antibodies Grant 8,114,965 - Maddon , et al. February 14, 2 | 2012-02-14 |
| Methods For Killing Psma-expressing, Taxane-resistant Cancer Cells App 20110250216 - Ma; Dangshe ; et al. | 2011-10-13 |
| PSMA antibodies and protein multimers Grant 7,850,971 - Maddon , et al. December 14, 2 | 2010-12-14 |
| Alpha-Emitting constructs and uses thereof App 20100278727 - Scheinberg; David A. ; et al. | 2010-11-04 |
| Alpha emitting constructs and uses thereof Grant 7,736,651 - Scheinberg , et al. June 15, 2 | 2010-06-15 |
| Compositions of PSMA antibodies App 20080286284 - Maddon; Paul J. ; et al. | 2008-11-20 |
| PSMA antibody-drug conjugates App 20070160617 - Ma; Dangshe ; et al. | 2007-07-12 |
| PSMA formulations and uses thereof App 20040161776 - Maddon, Paul J. ; et al. | 2004-08-19 |
| Anti-cd19 immunotoxins App 20040136908 - Olson, William C. ; et al. | 2004-07-15 |
| PSMA antibodies and protein multimers App 20040033229 - Maddon, Paul J. ; et al. | 2004-02-19 |
| Targeted alpha particle therapy using actinium-255 conjugates Grant 6,683,162 - Scheinberg , et al. January 27, 2 | 2004-01-27 |
| Bismuth-213 generator and uses thereof Grant 6,603,127 - Scheinberg , et al. August 5, 2 | 2003-08-05 |
| Actinium-225 complexes and conjugates for radioimmunotherapy App 20030086868 - Ma, Dangshe ; et al. | 2003-05-08 |
| Targeted alpha particle therapy using actinium-225 conjugates App 20020058007 - Scheinberg, David ; et al. | 2002-05-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 